ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC34224-10mg |
|
— |
AMARA peptide TFA
|
0 | C64H116F3N27O18S | |
GC34224-5mg |
|
— |
AMARA peptide TFA
|
0 | C64H116F3N27O18S | |
GC34224-1mg |
|
— |
AMARA peptide TFA
|
0 | C64H116F3N27O18S | |
GC34223-10mg |
|
— |
Dermorphin Analog
|
0 | C44H59N11O10 | |
GC34223-5mg |
|
— |
Dermorphin Analog
|
0 | C44H59N11O10 | |
GC34223-1mg |
|
— |
Dermorphin Analog
|
0 | C44H59N11O10 | |
GC34222-5mg |
|
— |
Galanin (1-16), mouse, porcine, rat TFA
|
0 | C80H117F3N20O23 | |
GC34222-1mg |
|
— |
Galanin (1-16), mouse, porcine, rat TFA
|
0 | C80H117F3N20O23 | |
GC34222-500μg |
|
— |
Galanin (1-16), mouse, porcine, rat TFA
|
0 | C80H117F3N20O23 | |
GC34221-10mg |
|
— |
GroES mobile loop
|
0 | C51H90N14O20 | |
GC34221-5mg |
|
— |
GroES mobile loop
|
0 | C51H90N14O20 | |
GC34221-1mg |
|
— |
GroES mobile loop
|
0 | C51H90N14O20 | |
GC34219-1mg |
|
— |
ATWLPPR Peptide TFA
|
0 | C42H62F3N11O11 | |
GC34219-10mM(1mLinDMSO) |
|
— |
ATWLPPR Peptide TFA
|
0 | C42H62F3N11O11 | |
GC34218-10mg |
|
946414-94-4 |
Nivolumab (BMS-936558)
|
0 | — | |
GC34218-1mg |
|
946414-94-4 |
Nivolumab (BMS-936558)
|
0 | — | |
GC34217-5mg |
|
205923-56-4 |
Cetuximab (C225)
|
0 | C6484H10042N1732O2023S36 | |
GC34217-1mg |
|
205923-56-4 |
Cetuximab (C225)
|
0 | C6484H10042N1732O2023S36 | |
GC34216-5mg |
|
216974-75-3 |
Bevacizumab (Anti-Human VEGF, Humanized Antibody)
|
0 | — | |
GC34215-25mg |
|
180288-69-1 |
Trastuzumab (Anti-Human HER2, Humanized Antibody)
|
0 | C6470H10012N1726O2013S42 | |